×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Atreca Inc. (BCEL) NASDAQ

$0.30 (0.01) (-3.82%)

Market Cap: $9.94M

As of 02/23/24 04:00 PM EST. Market closed.

(BCEL)

Atreca Inc. (BCEL)
NASDAQ

$0.30
(0.01) (-3.82%)

Market Cap: $9.94M

As of 02/23/24 04:00 PM EST. Market closed.

Add to Portfolio

atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics. with its immune repertoire capture™ (irc™) technology, atreca has an unparalleled insight into how cancer patients’ immune responses can drive better clinical outcomes. atreca was founded by scientists, ... read more

atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics. with its immune repertoire capture™ (irc™) technology, atreca has an unparalleled insight into how cancer patients’ immune responses can drive better clinical outcomes. atreca was founded by scientists, industry experts, and investors who share the vision that unlocking the immune response of today’s patients is the key to creating a new generation of therapies. atreca is looking for talented, entrepreneurial people who are dedicated to making a positive impact on human health. if you are interested in becoming part of the atreca team, our open positions can be found at: http://www.atreca.com/careers/ read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
John Orwin
Full Time Employees
101
URL
Address
450 East Jamie Court, California, South San Francisco, 94080.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
John Orwin
Full Time Employees
101
Address
450 East Jamie Court, California, South San Francisco, 94080.
PRICE CHART FOR ATRECA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.33
Previous Close
$0.31
Days Range
$0.29 - $0.34
52 week range
$0.10 - $1.60
Volume
920,319
Avg. Volume (30 days)
1,837,499
Market Cap
$9.94M
Dividend Yield
-
P/E
-
Shares Outstanding
32,908,634
Open
$0.33
Previous Close
$0.31
Days Range
$0.29 - $0.34
52 week range
$0.10 - $1.60
Volume
920,319
Avg. Volume (30 days)
1,837,499
Market Cap
$9.94M
Dividend Yield
-
P/E
-
Shares Outstanding
32,908,634
FINANCIAL STATEMENTS FOR ATRECA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ATRECA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
BAKER BROS. ADVISORS LPFormer 10% OwnerOct 19, 2023 Sale$0.40274,739110,5822,971,128Oct 23, 2023, 04:49 PM
Serafini TitoChief Strategy OfficerAug 02, 2023 Sale$0.955,4875,22572,817Aug 04, 2023, 06:56 PM
CROSS HERBChief Financial OfficerAug 02, 2023 Sale$0.955,4875,22572,817Aug 04, 2023, 06:55 PM
Gould Stephen EChief Scientific OfficerAug 02, 2023 Sale$0.954,0763,88128,424Aug 04, 2023, 06:54 PM
Courtney PhillipsGeneral Counsel & SecretaryAug 02, 2023 Sale$0.954,0763,88157,492Aug 04, 2023, 06:53 PM
Serafini TitoChief Strategy OfficerSep 02, 2022 Sale$1.787,64613,57334,554Sep 20, 2022, 06:13 PM
Orwin John APresident & CEOSep 02, 2022 Sale$1.7820,90837,116100,492Sep 20, 2022, 06:12 PM
CROSS HERBChief Financial OfficerSep 02, 2022 Sale$1.787,64613,57334,554Sep 20, 2022, 06:11 PM
Courtney PhillipsGeneral Counsel & SecretarySep 02, 2022 Sale$1.786,43211,41829,068Sep 20, 2022, 06:11 PM
Serafini TitoChief Strategy OfficerJun 28, 2022 Sale$2.0215,00030,265228,875Jun 30, 2022, 05:46 PM
Serafini TitoChief Strategy OfficerMar 04, 2022 Sale$5.0030,000150,000243,875Mar 08, 2022, 04:54 PM
Serafini TitoChief Strategy OfficerSep 27, 2021 Sale$6.5830,000197,541273,875Sep 28, 2021, 05:37 PM
Greenberg Norman MichaelChief Scientific OfficerMar 17, 2021 Option Exercise$4.815,00024,0502,916Mar 19, 2021, 07:52 PM
Greenberg Norman MichaelChief Scientific OfficerMar 17, 2021 Sale$16.735,00083,6500Mar 19, 2021, 07:52 PM
Robinson William HewittDirectorMar 15, 2021 Sale$16.895,00084,450368,948Mar 16, 2021, 05:45 PM
Serafini TitoChief Strategy OfficerMar 11, 2021 Sale$18.3110,000183,130355,375Mar 15, 2021, 07:09 PM
Greenberg Norman MichaelChief Scientific OfficerFeb 17, 2021 Option Exercise$5.165,00025,8005,000Feb 19, 2021, 07:56 PM
Greenberg Norman MichaelChief Scientific OfficerFeb 17, 2021 Sale$18.955,00094,7520Feb 19, 2021, 07:56 PM
Robinson William HewittDirectorFeb 16, 2021 Sale$19.075,00095,330373,948Feb 18, 2021, 09:55 PM
Serafini TitoChief Strategy OfficerFeb 11, 2021 Sale$18.9310,000189,272363,875Feb 16, 2021, 05:31 PM
Greenberg Norman MichaelChief Scientific OfficerJan 19, 2021 Option Exercise$5.165,00025,8005,000Jan 21, 2021, 07:04 PM
Greenberg Norman MichaelChief Scientific OfficerJan 19, 2021 Sale$15.215,00076,0450Jan 21, 2021, 07:04 PM
Greenberg Norman MichaelChief Scientific OfficerDec 17, 2020 Option Exercise$5.165,00025,8005,000Jan 21, 2021, 06:42 PM
Robinson William HewittDirectorJan 14, 2021 Sale$15.062,25934,011378,948Jan 15, 2021, 08:59 PM
Robinson William HewittDirectorJan 13, 2021 Sale$15.052,74141,239381,207Jan 15, 2021, 08:59 PM
Serafini TitoChief Strategy OfficerJan 11, 2021 Sale$15.0210,000150,192373,875Jan 13, 2021, 05:14 PM
Greenberg Norman MichaelChief Scientific OfficerDec 17, 2020 Option Exercise$4.565,00022,8005,000Dec 21, 2020, 06:48 PM
Greenberg Norman MichaelChief Scientific OfficerDec 17, 2020 Sale$16.615,00083,0510Dec 21, 2020, 06:48 PM
Robinson William HewittDirectorDec 14, 2020 Sale$16.675,00083,369383,948Dec 15, 2020, 07:47 PM
Serafini TitoChief Strategy OfficerDec 11, 2020 Sale$15.8710,000158,735383,875Dec 15, 2020, 05:16 PM
Greenberg Norman MichaelChief Scientific OfficerNov 27, 2020 Option Exercise$4.563,17514,4783,175Dec 01, 2020, 05:06 PM
Greenberg Norman MichaelChief Scientific OfficerNov 27, 2020 Sale$15.343,17548,7190Dec 01, 2020, 05:06 PM
Greenberg Norman MichaelChief Scientific OfficerNov 17, 2020 Option Exercise$4.561,8258,3221,825Nov 18, 2020, 05:25 PM
Greenberg Norman MichaelChief Scientific OfficerNov 17, 2020 Sale$15.041,82527,4480Nov 18, 2020, 05:25 PM
Robinson William HewittDirectorNov 16, 2020 Sale$15.005,00075,000388,948Nov 17, 2020, 06:30 PM
Serafini TitoChief Strategy OfficerNov 16, 2020 Sale$15.128,847133,784393,875Nov 17, 2020, 06:28 PM
Serafini TitoChief Strategy OfficerNov 11, 2020 Sale$15.101,15317,407399,067Nov 13, 2020, 06:16 PM
Greenberg Norman MichaelChief Scientific OfficerNov 10, 2020 Option Exercise$4.564,50020,5204,500Nov 12, 2020, 05:08 PM
Greenberg Norman MichaelChief Scientific OfficerNov 10, 2020 Sale$15.104,50067,9630Nov 12, 2020, 05:08 PM
Greenberg Norman MichaelChief Scientific OfficerOct 19, 2020 Option Exercise$4.565002,280500Oct 21, 2020, 05:32 PM
Greenberg Norman MichaelChief Scientific OfficerOct 19, 2020 Sale$15.125007,5620Oct 21, 2020, 05:32 PM
Robinson William HewittDirectorOct 13, 2020 Sale$15.715,00078,531393,948Oct 16, 2020, 04:01 PM
Serafini TitoChief Strategy OfficerOct 12, 2020 Sale$15.0010,000150,000400,220Oct 13, 2020, 07:29 PM
Serafini TitoChief Strategy OfficerOct 06, 2020 Sale$15.051,21818,334410,220Oct 08, 2020, 05:16 PM
Robinson William HewittDirectorSep 18, 2020 Sale$15.045,00075,188398,948Sep 22, 2020, 06:18 PM
Serafini TitoChief Strategy OfficerSep 18, 2020 Sale$15.118,782132,664411,438Sep 22, 2020, 06:17 PM
Robinson William HewittDirectorAug 14, 2020 Sale$15.005,00075,000403,948Aug 17, 2020, 08:26 PM
Serafini TitoChief Strategy OfficerAug 14, 2020 Sale$15.0010,000150,000420,220Aug 17, 2020, 08:22 PM
Robinson William HewittDirectorJul 13, 2020 Sale$20.235,000101,139412,542Jul 15, 2020, 09:46 PM
Serafini TitoChief Strategy OfficerJul 13, 2020 Sale$20.2010,000202,018437,349Jul 15, 2020, 09:45 PM
Greenberg Norman MichaelChief Scientific OfficerJul 01, 2020 Option Exercise$4.5610,27246,84010,272Jul 06, 2020, 06:02 PM
Greenberg Norman MichaelChief Scientific OfficerJul 01, 2020 Sale$21.8310,272224,2242,926Jul 06, 2020, 06:02 PM
Serafini TitoChief Strategy OfficerJun 25, 2020 Sale$25.0160015,008440,220Jun 29, 2020, 07:39 PM
Robinson William HewittDirectorJun 25, 2020 Sale$25.0260015,010413,948Jun 29, 2020, 07:38 PM
Robinson William HewittDirectorJun 22, 2020 Sale$20.05681,363414,548Jun 23, 2020, 05:42 PM
Robinson William HewittDirectorJun 19, 2020 Sale$20.0310,245205,169414,616Jun 23, 2020, 05:42 PM
Serafini TitoChief Strategy OfficerJun 22, 2020 Sale$20.054969,945440,820Jun 23, 2020, 05:40 PM
Serafini TitoChief Strategy OfficerJun 19, 2020 Sale$20.034,60492,203441,316Jun 23, 2020, 05:40 PM
Robinson William HewittDirectorJun 15, 2020 Sale$18.555,00092,728428,856Jun 17, 2020, 05:35 PM
Serafini TitoChief Strategy OfficerJun 11, 2020 Sale$16.4710,000164,686447,334Jun 12, 2020, 05:49 PM
Greenberg Norman MichaelChief Scientific OfficerJun 01, 2020 Option Exercise$4.5615,00068,40015,000Jun 03, 2020, 05:03 PM
Greenberg Norman MichaelChief Scientific OfficerJun 01, 2020 Sale$18.3815,000275,7600Jun 03, 2020, 05:03 PM
Robinson William HewittDirectorMay 28, 2020 Sale$20.0160012,003429,861May 29, 2020, 06:50 PM
Serafini TitoChief Strategy OfficerMay 28, 2020 Sale$20.0070014,003455,920May 29, 2020, 06:48 PM
Serafini TitoChief Strategy OfficerMay 27, 2020 Sale$20.001002,000456,620May 29, 2020, 06:48 PM
Robinson William HewittDirectorMay 26, 2020 Sale$20.003877,740430,461May 27, 2020, 05:58 PM
Serafini TitoChief Strategy OfficerMay 26, 2020 Sale$20.002004,000456,720May 27, 2020, 05:57 PM
Robinson William HewittDirectorMay 18, 2020 Sale$20.001,60032,003430,848May 19, 2020, 05:41 PM
Robinson William HewittDirectorMay 15, 2020 Sale$20.002,10042,000432,448May 19, 2020, 05:41 PM
Serafini TitoChief Strategy OfficerMay 18, 2020 Sale$20.001,70034,004456,920May 19, 2020, 05:39 PM
Serafini TitoChief Strategy OfficerMay 15, 2020 Sale$20.002,20044,000458,620May 19, 2020, 05:39 PM
Robinson William HewittDirectorMay 13, 2020 Sale$16.825,00084,105434,748May 15, 2020, 05:45 PM
Serafini TitoChief Strategy OfficerMay 11, 2020 Sale$18.0010,000180,025467,108May 13, 2020, 07:35 PM
Greenberg Norman MichaelChief Scientific OfficerMay 07, 2020 Option Exercise$4.565,00022,8005,000May 08, 2020, 05:28 PM
Greenberg Norman MichaelChief Scientific OfficerMay 07, 2020 Sale$18.005,00090,0000May 08, 2020, 05:28 PM
Greenberg Norman MichaelChief Scientific OfficerMay 01, 2020 Option Exercise$4.5610,00045,60010,000May 04, 2020, 05:57 PM
Greenberg Norman MichaelChief Scientific OfficerMay 01, 2020 Sale$15.0310,000150,2760May 04, 2020, 05:57 PM
Serafini TitoChief Strategy OfficerApr 16, 2020 Sale$16.2810,000162,761474,539Apr 20, 2020, 05:32 PM
Robinson William HewittDirectorApr 16, 2020 Sale$16.255,00081,271441,348Apr 20, 2020, 05:30 PM
Greenberg Norman MichaelChief Scientific OfficerApr 14, 2020 Option Exercise$4.565,00022,8005,000Apr 16, 2020, 06:28 PM
Greenberg Norman MichaelChief Scientific OfficerApr 14, 2020 Sale$18.005,00090,0000Apr 16, 2020, 06:28 PM
Greenberg Norman MichaelChief Scientific OfficerApr 08, 2020 Option Exercise$4.568,00036,4808,000Apr 10, 2020, 05:17 PM
Greenberg Norman MichaelChief Scientific OfficerApr 08, 2020 Sale$15.018,000120,1010Apr 10, 2020, 05:17 PM
Greenberg Norman MichaelChief Scientific OfficerApr 01, 2020 Option Exercise$4.562,0009,1202,000Apr 02, 2020, 06:18 PM
Greenberg Norman MichaelChief Scientific OfficerApr 01, 2020 Sale$15.212,00030,4220Apr 02, 2020, 06:18 PM
Orwin John APresident & CEOMar 17, 2020 Buy$12.796,00076,7406,000Mar 19, 2020, 06:52 PM
Greenberg Norman MichaelChief Scientific OfficerMar 02, 2020 Option Exercise$4.5615,00068,40015,000Mar 04, 2020, 06:18 PM
Greenberg Norman MichaelChief Scientific OfficerMar 02, 2020 Sale$24.0715,000360,9849,288Mar 04, 2020, 06:18 PM
Cavet GuyChief Technical OfficerFeb 25, 2020 Option Exercise$4.562,1009,57694,858Feb 26, 2020, 06:24 PM
Cavet GuyChief Technical OfficerFeb 25, 2020 Sale$20.647,100146,53888,661Feb 26, 2020, 06:24 PM
Greenberg Norman MichaelChief Scientific OfficerFeb 03, 2020 Option Exercise$4.5615,00068,40015,000Feb 04, 2020, 06:00 PM
Greenberg Norman MichaelChief Scientific OfficerFeb 03, 2020 Sale$19.6515,000294,7685,620Feb 04, 2020, 06:00 PM
Cavet GuyChief Technical OfficerJan 27, 2020 Sale$20.0010,000200,00092,758Jan 29, 2020, 04:05 PM
Greenberg Norman MichaelChief Scientific OfficerJan 24, 2020 Option Exercise$4.565,00022,8005,000Jan 27, 2020, 04:10 PM
Greenberg Norman MichaelChief Scientific OfficerJan 24, 2020 Sale$18.475,00092,3460Jan 27, 2020, 04:10 PM
Cavet GuyChief Technical OfficerJan 17, 2020 Option Exercise$5.161,9199,902109,677Jan 22, 2020, 04:16 PM
Cavet GuyChief Technical OfficerJan 17, 2020 Sale$14.906,919103,065103,282Jan 22, 2020, 04:16 PM
Greenberg Norman MichaelChief Scientific OfficerJan 17, 2020 Option Exercise$4.5610,00045,60010,000Jan 22, 2020, 04:15 PM
Greenberg Norman MichaelChief Scientific OfficerJan 17, 2020 Sale$14.9010,000148,9929,092Jan 22, 2020, 04:15 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
BAKER BROS. ADVISORS LPFormer 10% Owner10/19/2023110,582
Serafini TitoChief Strategy Officer08/02/20235,225
CROSS HERBChief Financial Officer08/02/20235,225
Gould Stephen EChief Scientific Officer08/02/20233,881
Courtney PhillipsGeneral Counsel & Secretary08/02/20233,881
Serafini TitoChief Strategy Officer09/02/202213,573
Orwin John APresident & CEO09/02/202237,116
CROSS HERBChief Financial Officer09/02/202213,573
Courtney PhillipsGeneral Counsel & Secretary09/02/202211,418
Serafini TitoChief Strategy Officer06/28/202230,265
Serafini TitoChief Strategy Officer03/04/2022150,000
Serafini TitoChief Strategy Officer09/27/2021197,541
Greenberg Norman MichaelChief Scientific Officer03/17/202124,050
Greenberg Norman MichaelChief Scientific Officer03/17/202183,650
Robinson William HewittDirector03/15/202184,450
Serafini TitoChief Strategy Officer03/11/2021183,130
Greenberg Norman MichaelChief Scientific Officer02/17/202125,800
Greenberg Norman MichaelChief Scientific Officer02/17/202194,752
Robinson William HewittDirector02/16/202195,330
Serafini TitoChief Strategy Officer02/11/2021189,272
Greenberg Norman MichaelChief Scientific Officer01/19/202125,800
Greenberg Norman MichaelChief Scientific Officer01/19/202176,045
Greenberg Norman MichaelChief Scientific Officer12/17/202025,800
Robinson William HewittDirector01/14/202134,011
Robinson William HewittDirector01/13/202141,239
Serafini TitoChief Strategy Officer01/11/2021150,192
Greenberg Norman MichaelChief Scientific Officer12/17/202022,800
Greenberg Norman MichaelChief Scientific Officer12/17/202083,051
Robinson William HewittDirector12/14/202083,369
Serafini TitoChief Strategy Officer12/11/2020158,735
Greenberg Norman MichaelChief Scientific Officer11/27/202014,478
Greenberg Norman MichaelChief Scientific Officer11/27/202048,719
Greenberg Norman MichaelChief Scientific Officer11/17/20208,322
Greenberg Norman MichaelChief Scientific Officer11/17/202027,448
Robinson William HewittDirector11/16/202075,000
Serafini TitoChief Strategy Officer11/16/2020133,784
Serafini TitoChief Strategy Officer11/11/202017,407
Greenberg Norman MichaelChief Scientific Officer11/10/202020,520
Greenberg Norman MichaelChief Scientific Officer11/10/202067,963
Greenberg Norman MichaelChief Scientific Officer10/19/20202,280
Greenberg Norman MichaelChief Scientific Officer10/19/20207,562
Robinson William HewittDirector10/13/202078,531
Serafini TitoChief Strategy Officer10/12/2020150,000
Serafini TitoChief Strategy Officer10/06/202018,334
Robinson William HewittDirector09/18/202075,188
Serafini TitoChief Strategy Officer09/18/2020132,664
Robinson William HewittDirector08/14/202075,000
Serafini TitoChief Strategy Officer08/14/2020150,000
Robinson William HewittDirector07/13/2020101,139
Serafini TitoChief Strategy Officer07/13/2020202,018
Greenberg Norman MichaelChief Scientific Officer07/01/202046,840
Greenberg Norman MichaelChief Scientific Officer07/01/2020224,224
Serafini TitoChief Strategy Officer06/25/202015,008
Robinson William HewittDirector06/25/202015,010
Robinson William HewittDirector06/22/20201,363
Robinson William HewittDirector06/19/2020205,169
Serafini TitoChief Strategy Officer06/22/20209,945
Serafini TitoChief Strategy Officer06/19/202092,203
Robinson William HewittDirector06/15/202092,728
Serafini TitoChief Strategy Officer06/11/2020164,686
Greenberg Norman MichaelChief Scientific Officer06/01/202068,400
Greenberg Norman MichaelChief Scientific Officer06/01/2020275,760
Robinson William HewittDirector05/28/202012,003
Serafini TitoChief Strategy Officer05/28/202014,003
Serafini TitoChief Strategy Officer05/27/20202,000
Robinson William HewittDirector05/26/20207,740
Serafini TitoChief Strategy Officer05/26/20204,000
Robinson William HewittDirector05/18/202032,003
Robinson William HewittDirector05/15/202042,000
Serafini TitoChief Strategy Officer05/18/202034,004
Serafini TitoChief Strategy Officer05/15/202044,000
Robinson William HewittDirector05/13/202084,105
Serafini TitoChief Strategy Officer05/11/2020180,025
Greenberg Norman MichaelChief Scientific Officer05/07/202022,800
Greenberg Norman MichaelChief Scientific Officer05/07/202090,000
Greenberg Norman MichaelChief Scientific Officer05/01/202045,600
Greenberg Norman MichaelChief Scientific Officer05/01/2020150,276
Serafini TitoChief Strategy Officer04/16/2020162,761
Robinson William HewittDirector04/16/202081,271
Greenberg Norman MichaelChief Scientific Officer04/14/202022,800
Greenberg Norman MichaelChief Scientific Officer04/14/202090,000
Greenberg Norman MichaelChief Scientific Officer04/08/202036,480
Greenberg Norman MichaelChief Scientific Officer04/08/2020120,101
Greenberg Norman MichaelChief Scientific Officer04/01/20209,120
Greenberg Norman MichaelChief Scientific Officer04/01/202030,422
Orwin John APresident & CEO03/17/202076,740
Greenberg Norman MichaelChief Scientific Officer03/02/202068,400
Greenberg Norman MichaelChief Scientific Officer03/02/2020360,984
Cavet GuyChief Technical Officer02/25/20209,576
Cavet GuyChief Technical Officer02/25/2020146,538
Greenberg Norman MichaelChief Scientific Officer02/03/202068,400
Greenberg Norman MichaelChief Scientific Officer02/03/2020294,768
Cavet GuyChief Technical Officer01/27/2020200,000
Greenberg Norman MichaelChief Scientific Officer01/24/202022,800
Greenberg Norman MichaelChief Scientific Officer01/24/202092,346
Cavet GuyChief Technical Officer01/17/20209,902
Cavet GuyChief Technical Officer01/17/2020103,065
Greenberg Norman MichaelChief Scientific Officer01/17/202045,600
Greenberg Norman MichaelChief Scientific Officer01/17/2020148,992
Load More Insider Transactions
FUNDS WITH A POSITION IN ATRECA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAKER BROS. ADVISORS LP2,177,4990.00327%-38.36%Other
BLACKROCK INC.637,9740%-46.19%Other
RENAISSANCE TECHNOLOGIES LLC356,0240.00007%4.12%Other
GEODE CAPITAL MANAGEMENT, LLC295,4710%12.38%Other
CHANGE IN SHARES OUTSTANDING FOR ATRECA INC
STOCK BUYBACKS FOR ATRECA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.51%
1Q
09/30/2023
03/31/2023
0.67%
2Q
09/30/2023
12/31/2022
0.72%
3Q
09/30/2023
09/30/2022
1.64%
4Q
09/30/2023
06/30/2022
1.98%
5Q
09/30/2023
03/31/2022
3.61%
6Q
09/30/2023
12/31/2021
4.95%
7Q
09/30/2023
09/30/2021
6.60%
8Q
09/30/2023
06/30/2021
6.67%
9Q
09/30/2023
03/31/2021
6.82%
10Q
09/30/2023
12/31/2020
7.06%
11Q
09/30/2023
09/30/2020
13.34%
12Q
09/30/2023
06/30/2020
39.83%
13Q
09/30/2023
03/31/2020
40.45%
14Q
09/30/2023
09/30/2019
40.80%
16Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.51%
1Q
03/31/2023
0.67%
2Q
12/31/2022
0.72%
3Q
09/30/2022
1.64%
4Q
06/30/2022
1.98%
5Q
03/31/2022
3.61%
6Q
12/31/2021
4.95%
7Q
09/30/2021
6.60%
8Q
06/30/2021
6.67%
9Q
03/31/2021
6.82%
10Q
12/31/2020
7.06%
11Q
09/30/2020
13.34%
12Q
06/30/2020
39.83%
13Q
03/31/2020
40.45%
14Q
09/30/2019
40.80%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ATRECA INC
LOADING...